Casp9 Cancer Research Results

Casp9, Caspase-9: Click to Expand ⟱
Source:
Type:
Caspase-9 is the apoptotic initiator protease of the intrinsic or mitochondrial apoptotic pathway, which is activated at multi-protein activation platforms.
Caspases are divided into two groups: the initiator caspases (caspase-2, -8, -9 and -10), which are the first to be activated in response to a signal, and the executioner caspases (caspase-3, -6, and -7) that carry out the demolition phase of apoptosis.
Caspase-9:
Role: Initiator caspase in the intrinsic apoptotic pathway.
Cancers: Frequently studied in leukemia and solid tumors.
Prognosis: Reduced expression is often linked to chemoresistance and poor prognosis.


Scientific Papers found: Click to Expand⟱
6461- 1,8-Cin,    1,8-cineole (eucalyptol): A versatile phytochemical with therapeutic applications across multiple diseases
- Review, AD, NA - Review, Var, NA
*Inflam↓, *antiOx↑, *neuroP↑, *BioAv↑, *Half-Life↝, *toxicity↓, *PGE2↓, *TNF-α↓, *IL1β↓, *NO↓, *NF-kB↓, *PPARγ↓, COX2/PTGS2↓, *ROS↓, *SOD↑, *Catalase↑, *TAC↑, *MDA↓, *lipid-P↓, *NRF2↑, *HO-1↑, *NADPH↑, *GPx↑, *AntiBio↑, *Synergy↑, *AntiFungal↑, *AntiViral↑, *TRPA1↑, Synergy↑, TumCCA↑, ROS↑, MAPK↝, mTOR↝, Apoptosis↑, survivin↓, Akt↓, p38↑, cl‑PARP↑, cl‑Casp3⇅, P53↑, BAX↑, Cyt‑c↑, Casp9↑, Dose↝, *Aβ↓, *tau↓, *GSK‐3β↓, *BACE/β-secretase↓, *cardioP↑, MFN2↑, *antiAll↑,
1295- AG,  Cisplatin,    Chemosensitizing Effect of Astragalus Polysaccharides on Nasopharyngeal Carcinoma Cells by Inducing Apoptosis and Modulating Expression of Bax/Bcl-2 Ratio and Caspases
- in-vivo, Laryn, NA
AntiTum↑, Apoptosis↑, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, Bax:Bcl2↑,
5431- AG,    Advances in research on the anti-tumor mechanism of Astragalus polysaccharides
- Review, Var, NA
AntiTum↑, TumCG↓, TumCI↓, Apoptosis↑, Imm↑, Bcl-2↓, BAX↑, Wnt↓, β-catenin/ZEB1↓, TumCG↓, miR-133a-3p↑, JNK↓, Fas↑, P53↑, P21↑, NOTCH1↓, NOTCH3↓, TumCP↓, TumCCA↑, GPx4↓, xCT/SLC7A11↓, AMPK↑, Beclin-1/ATG6↑, NF-kB↓, EMT↓, Vim↓, TumMeta↓, VEGF↓, EGFR↓, eff↑, eff↑, MMP↓, P-gp/ABCB1↓, MMP9↓, ChemoSen↑, SIRT1↓, SREBP1/SREBF1↓, TumAuto↑, PI3K↓, mTOR↓, Casp3↑, Casp9↑, CD133↓, CD44↓, CSCs↓, QoL↑,
5238- AgNPs,    β-Sitosterol-assisted silver nanoparticles activates Nrf2 and triggers mitochondrial apoptosis via oxidative stress in human hepatocellular cancer cell line
- in-vitro, HCC, HepG2
TumCP↓, ROS↑, NRF2↑, BAX↑, P53↑, Cyt‑c↑, Casp9↑, Casp3↑, Bcl-2↓,
5145- AgNPs,    Silver nanoparticles induce irremediable endoplasmic reticulum stress leading to unfolded protein response dependent apoptosis in breast cancer cells
- in-vitro, BC, MCF7 - in-vitro, BC, T47D
Bacteria↓, Apoptosis↑, ER Stress↑, UPR↑, PERK↑, IRE1↑, ATF6↑, ATF4↑, CHOP/DDIT3↑, Casp9↑, Casp7↑, Mcl-1↓, XIAP↓, PARP↝, selectivity↑,
4438- AgNPs,  ART/DHA,    Biogenic synthesis of AgNPs using Artemisia oliveriana extract and their biological activities for an effective treatment of lung cancer
- in-vitro, Lung, A549
EPR↑, BAX↑, Bcl-2↑, Casp3↑, Casp9↑, DNAdam↑, TumCCA↑, Apoptosis↑,
7426- AgNPs,  CS,    Silver Nanoparticles Formulation of Flower Head's Polyphenols of Cynara scolymus L.: A Promising Candidate against Prostate (PC-3) Cancer Cell Line through Apoptosis Activation
- in-vitro, Pca, PC3 - in-vitro, Lung, A549
*antiOx↑, tumCV↓, eff↑, Dose↝, P53↑, BAX↑, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓,
334- AgNPs,    Silver-Based Nanoparticles Induce Apoptosis in Human Colon Cancer Cells Mediated Through P53
- in-vitro, Colon, HCT116
Bax:Bcl2↑, P53↑, P21↑, Casp3↑, Casp8↑, Casp9↑, Akt↓, NF-kB↓, DNAdam↑, TumCCA↑,
327- AgNPs,  MS-275,    Combination Effect of Silver Nanoparticles and Histone Deacetylases Inhibitor in Human Alveolar Basal Epithelial Cells
- in-vitro, Lung, A549
Apoptosis↑, ROS↑, LDH↓, TNF-α↑, mtDam↑, TumAuto↑, Casp3↑, Casp9↑, DNAdam↑,
324- AgNPs,  CPT,    Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells
- in-vitro, Cerv, HeLa
ROS↑, Casp3↑, Casp9↑, Casp6↑, GSH↓, SOD↓, GPx↓, MMP↓, P53↑, P21↑, Cyt‑c↑, BID↑, BAX↑, Bcl-2↓, Bcl-xL↓, Akt↓, Raf↓, ERK↓, MAP2K1/MEK1↓, JNK↑, p38↑,
369- AgNPs,    Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis
- in-vitro, Liver, NA
ROS↑, GSH↓, DNAdam↑, lipid-P↝, Apoptosis↑, BAX↑, Bcl-2↓, MMP↓, Casp9↑, Casp3↑, JNK↑,
363- AgNPs,    Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis
- in-vitro, Liver, NA
ROS↑, lipid-P↑, Apoptosis↑, BAX↑, Bcl-2↓, MMP↓, Cyt‑c↑, Casp3↑, Casp9↑, JNK↑,
359- AgNPs,    Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cells
- in-vitro, Lung, A549 - in-vitro, Nor, HEK293
Casp3↑, Casp9↑, P53↑, ROS↑, MMP2↓, MMP9↓, TumCCA↑, *toxicity↓, TumCMig↓, TumCI↓,
346- AgNPs,  RSQ,    Investigating Silver Nanoparticles and Resiquimod as a Local Melanoma Treatment
- in-vivo, Melanoma, SK-MEL-28 - in-vivo, Melanoma, WM35
ROS↑, Ca+2↝, Casp3↑, Casp8↑, Casp9↑, CD4+↑, CD8+↑, tumCV↓, eff↓, *toxicity↓,
350- AgNPs,    Cytotoxic and Apoptotic Effects of Green Synthesized Silver Nanoparticles via Reactive Oxygen Species-Mediated Mitochondrial Pathway in Human Breast Cancer Cells
- in-vitro, BC, MCF7
ROS↑, MMP↓, P53↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓,
351- AgNPs,    Study of antitumor activity in breast cell lines using silver nanoparticles produced by yeast
- in-vitro, BC, MCF7 - in-vitro, BC, T47D
Casp9↑, Casp3↑, Casp7↑, Bcl-2↓,
397- AgNPs,  GEM,    Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment
- in-vitro, Ovarian, A2780S
P53↑, P21↑, BAX↑, Bak↑, Cyt‑c↑, Casp3↑, Casp9↑, Bcl-2↓, ROS↑, MMP↓,
384- AgNPs,    Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating cytotoxicity- and differentiation-mediated cancer therapy
- in-vitro, Testi, F9
LDH↓, ROS↑, mtDam↑, DNAdam↑, P53↑, P21↑, BAX↑, Casp3↑, Bcl-2↓, Casp9↑, Nanog↓, OCT4↓,
387- AgNPs,    Silver nanoparticles induce mitochondria-dependent apoptosis and late non-canonical autophagy in HT-29 colon cancer cells
- in-vitro, Colon, HT-29
Cyt‑c↑, P53↑, BAX↑, Casp3↑, Casp9↑, Casp12↑, Beclin-1/ATG6↑, CHOP/DDIT3↑, LC3s↑, XBP-1↑,
9219- AITC,    Sensitivity of allyl isothiocyanate to induce apoptosis via ER stress and the mitochondrial pathway upon ROS production in colorectal adenocarcinoma cells
- in-vitro, CRC, HT-29
TumCG↓, TumNum↓, tumCV↓, TumCCA↑, Casp9↑, Casp3↑, MMP↓, Cyt‑c↑, AIF↑, Endon↑, Ca+2↝, ER Stress↑, Cal1↑, ATF6↑, GRP78/BiP↑, GRP94↑, CHOP/DDIT3↑, CASP4↑, ROS↑,
9220- AITC,    Allyl isothiocyanate arrests cancer cells in mitosis, and mitotic arrest in turn leads to apoptosis via Bcl-2 protein phosphorylation
- in-vitro, Bladder, NA
TumCCA↑, mitA↑, Apoptosis↑, α-tubulin↓, Cyt‑c↑, Casp9↑, Casp3↑, JNK↑, AntiBio↑, AntiCan↑, BioAv↑,
9224- AITC,    Allyl Isothiocyanate (AITC) Induces Apoptotic Cell Death In Vitro and Exhibits Anti-Tumor Activity in a Human Glioblastoma GBM8401/ luc2 Model
- vitro+vivo, GBM, NA
tumCV↓, Apoptosis↑, Bcl-2↓, Mcl-1↓, BAX↑, Casp3↑, Casp8↑, Casp9↑, Dose↝, TumCG↓, TumVol↓, TumW↓, toxicity↓, XIAP↓, MMP9↓, VEGF↓,
9229- AITC,    Allyl isothiocyanate as a cancer chemopreventive phytochemical
- Review, Var, NA
BioAv↑, BioAv↑, eff↑, selectivity↑, MMP↓, Casp3↑, Casp8↑, Casp9↑, Casp12↑,
9235- AITC,    Anticancer Activity, Mechanism, and Delivery of Allyl Isothiocyanate
- Review, Var, NA
tumCV↓, Apoptosis↑, TumCCA↑, CDK1↓, cycA1/CCNA1↓, CycB/CCNB1↓, DNAdam↑, p‑Akt↓, p‑mTOR↓, Casp3↑, Casp9↑, ROS↑, MMP↓, selectivity↑, TumAuto↑, Beclin-1/ATG6↑, HATs↓, HDAC↓, HMTs↓, p‑ERK↑, P21↑, CDC25↓, CDK1↓, FasL↑, TRAIL↑, MAPK↑, ATF6↑, GRP94↑, GRP78/BiP↑, Cal1↑, cal2↑, CHOP/DDIT3↑, BAX↑, Endoglin↑, AIF↑, APAF1↑, Cyt‑c↑, TIMP1↑, GSTs↑, GGT/CD224↑, NRF2↓, BioAv↓, BioAv↑, Risk↓,
5168- AL,    Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells
- in-vitro, Var, NA
TumCG↓, Casp3↑, Casp8↑, Casp9↑, chemoPv↑,
245- AL,    Allicin: a promising modulator of apoptosis and survival signaling in cancer
- Review, Var, NA
Fas↑, Bcl-2↓, BAX↑, PI3k/Akt/mTOR↝, Casp3↑, Casp8↑, Casp9↑, Apoptosis↓, *toxicity↓, Cyt‑c↑,
251- AL,    Inhibition of allicin in Eca109 and EC9706 cells via G2/M phase arrest and mitochondrial apoptosis pathway
- in-vitro, ESCC, Eca109 - in-vitro, ESCC, EC9706 - in-vivo, NA, NA
Apoptosis↑, P53↑, P21↑, CHK1↑, CycB/CCNB1↓, BAX↑, Casp3↑, Casp9↑, Cyt‑c↑,
241- AL,    Role of p38 MAPK activation and mitochondrial cytochrome-c release in allicin-induced apoptosis in SK-N-SH cells
- in-vitro, neuroblastoma, SK-N-SH
Casp3↑, Casp9↑, p38↑, MAPK↑, Cyt‑c↑, Apoptosis↑,
239- AL,    Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways
- in-vitro, GC, SGC-7901
Apoptosis↑, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, BAX↑, Fas↑, tumCV↓, DNAdam↑, ROS↑, Telomerase↓,
234- AL,    Allicin Induces Anti-human Liver Cancer Cells through the p53 Gene Modulating Apoptosis and Autophagy
- in-vitro, HCC, Hep3B
ROS↑, *toxicity∅, MMP↓, BAX↑, Bcl-2↓, AIF↑, Casp3↑, Casp8↑, Casp9↑, eff↓, γH2AX↑, selectivity↑, DNA-PK↑,
2655- AL,    Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities
- Review, GC, NA
TGF-β↓, cycD1/CCND1↓, cycE/CCNE↓, CDK1↓, DNAdam↑, ROS↑, BAX↑, JNK↑, MMP↓, p38↑, MAPK↑, Fas↑, Cyt‑c↑, Casp8↑, PARP↑, Casp3↑, Casp9↑, Ca+2↑, ER Stress↑, P21↑, CDK2↓, CDK6↑, TumCCA↑, CDK4↓,
2660- AL,    Allicin: A review of its important pharmacological activities
- Review, AD, NA - Review, Var, NA - Review, Park, NA - Review, Stroke, NA
*Inflam↓, AntiCan↑, *antiOx↑, *cardioP↑, *hepatoP↑, *BBB↑, *Half-Life↝, *H2S↑, *BP↓, *neuroP↑, *cognitive↑, *neuroP↑, *ROS↓, *GutMicro↑, *LDH↓, *ROS↓, *lipid-P↓, *antiOx↑, *other↑, *PI3K↓, *Akt↓, *NF-kB↓, *NO↓, *iNOS↓, *PGE2↓, *COX2/PTGS2↓, *IL6↓, *TNF-α↓, *MPO↓, *Synergy↑, *NRF2↑, *Keap1↓, *TBARS↓, *creat↓, *LDH↓, *AST↓, *ALAT↓, *MDA↓, *SOD↑, *GSH↑, *GSTs↑, *memory↑, chemoP↑, IL8↓, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, Casp12↑, p38↑, Fas↑, P53↑, P21↑, CHK1↓, CycB/CCNB1↓, GSH↓, ROS↑, TumCCA↑, Hif1a↓, Bcl-2↓, VEGF↓, TumCMig↓, STAT3↓, VEGFR2/KDR/Flk1↓, p‑FAK↓,
3541- ALA,    Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology
- Review, Var, NA
*antiOx↑, *IronCh↑, *GSH↑, *BBB↑, Apoptosis↑, MMP↓, ROS↑, lipid-P↑, PARP1↑, Casp3↑, Casp9↑, *NRF2↑, *GSH↑, *ROS↓, RenoP↑, ChemoSen↑, *BG↓,
278- ALA,    The Multifaceted Role of Alpha-Lipoic Acid in Cancer Prevention, Occurrence, and Treatment
- Review, Var, NA
ROS↑, NRF2↑, Inflam↓, frataxin↑, *BioAv↓, ChemoSen↑, Hif1a↓, Synergy↑, FAK↓, ITGB1↓, MMP2↓, MMP9↓, EMT↓, Snail↓, Vim↓, Zeb1↓, P53↑, MGMT↓, Mcl-1↓, Bcl-xL↓, Bcl-2↓, survivin↓, Casp3↑, Casp9↑, BAX↑, p‑Akt↓, GSK‐3β↓, *antiOx↑, *ROS↓, selectivity↑, angioG↓, MMPs↓, NF-kB↓, ITGB3↓, NADPH↓,
281- ALA,    Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation
- in-vitro, Lung, H460
mt-ROS↑, Apoptosis↑, Casp9↑, Bcl-2↓, eff↓, eff↑, H2O2↑, Dose↑,
267- ALA,    α-Lipoic Acid Targeting PDK1/NRF2 Axis Contributes to the Apoptosis Effect of Lung Cancer Cells
- vitro+vivo, Lung, A549 - vitro+vivo, Lung, PC9
Apoptosis↑, ROS↑, PDK1 / PDPK1↓, NRF2↓, PDK1 / PDPK1↓, Bcl-2↓, Casp9↑, Dose∅,
7399- Amla,    Molecular Mechanisms of Cancer Prevention by Gooseberry (Phyllanthus emblica)
- Review, Var, NA
*Dose↝, *Inflam↓, *AntiCan↑, *antiOx↑, *neuroP↑, *hepatoP↑, *cardioP↑, *P450↓, *SOD↑, *GPx↑, *Catalase↑, *ROS↓, *CD4+↑, *CD19↑, *NK cell↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, Fas↑, BAX↑, Bcl-2↓, *IL10↑, *TNF-α↓, *IL6↓, *iNOS↓, *COX2/PTGS2↓, *GSTs↑, *NF-kB↓, *AP-1↓, *cJun↓, *lipid-P↓, TumCG↓, DNAdam↑, TumCCA↑, MMP2↓, MMP9↓,
1078- And,    Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway
- in-vitro, BC, MDA-MB-231 - in-vitro, Nor, HUVECs - in-vivo, BC, MCF7 - in-vitro, BC, T47D - in-vitro, BC, BT549 - in-vitro, BC, MDA-MB-361
TumCP↓, COX2/PTGS2↓, *angioG↓, Cyt‑c↑, CREB2↓, cFos↓, NF-kB↓, HATs↓, cl‑Casp3↑, cl‑Casp9↑, Bax:Bcl2↑, Apoptosis↑, *toxicity↓,
1009- And,  5-FU,    Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer
- in-vivo, CRC, HCT116 - in-vitro, CRC, SW480
ChemoSen↑, Casp9↑, Ferroptosis↑, Wnt/(β-catenin)↓, FTL↑, TP53↑, ACSL5↑, GCLC↑, GCLM↑, SAT1↑, STEAP3↑, ACSL5↑,
6396- ANE,  FEO,    Anethole Inhibits the Proliferation of Human Prostate Cancer Cells via Induction of Cell Cycle Arrest and Apoptosis
- in-vitro, Pca, PC3
TumCP↓, TumCG↓, TumCMig↓, CSCs↓, ROS↑, MPT↑, Casp3↑, Casp9↑, DNAdam↑, cl‑PARP↑, Bax:Bcl2↑, TumCCA↑, cycD1/CCND1↓, CDK4↓, cMyc↓, P21↑, p27/CDKN1B↑, NF-kB↓, eff↑,
6398- ANE,    trans-Anethole Abrogates Cell Proliferation and Induces Apoptosis through the Mitochondrial-Mediated Pathway in Human Osteosarcoma Cells
- in-vitro, OS, MG63
*Inflam↓, *AntiTum↑, TumCCA↓, ROS↑, MMP↓, Casp3↑, Casp9↑, P53↑, Bcl-xL↓, MPT↑,
1563- Api,  MET,    Metformin-induced ROS upregulation as amplified by apigenin causes profound anticancer activity while sparing normal cells
- in-vitro, Nor, HDFa - in-vitro, PC, AsPC-1 - in-vitro, PC, MIA PaCa-2 - in-vitro, Pca, DU145 - in-vitro, Pca, LNCaP - in-vivo, NA, NA
selectivity↑, selectivity↑, selectivity↓, ROS↑, Synergy↑, tumCV↓, MMP↓, Dose∅, eff↓, DNAdam↑, Apoptosis↑, TumAuto↑, Necroptosis↑, p‑P53↑, BIM↑, BAX↑, p‑PARP↑, Casp3↑, Casp8↑, Casp9↑, Cyt‑c↑, Bcl-2↓, AIF↑, p62↑, LC3B↑, MLKL↑, p‑MLKL↓, RIP3↑, p‑RIP3↑, TumCG↑, TumW↓,
584- Api,  Cisplatin,    Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms
- in-vivo, Var, NA
Beclin-1/ATG6↑, Casp3↑, Casp9↑, JNK↑, Mcl-1↓, Ki-67↓,
310- Api,    Apigenin inhibits renal cell carcinoma cell proliferation
- vitro+vivo, RCC, ACHN - in-vitro, RCC, 786-O - in-vitro, RCC, Caki-1 - in-vitro, RCC, HK-2
TumCCA↑, p‑ATM↑, p‑CHK1↑, p‑CDC25↑, p‑cDC2↑, P53↑, BAX↑, Casp9↑, Casp3↑,
206- Api,    Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress
- in-vitro, Lung, H1299 - in-vitro, Lung, H460 - in-vitro, Lung, A549 - in-vitro, CRC, HCT116 - in-vitro, Melanoma, A375 - in-vitro, Lung, H2030 - in-vitro, CRC, SW480
Glycolysis↓, lactateProd↓, PGK1↓, ALDOA↓, GLUT1↓, ENO1↓, ATP↓, Casp9↑, Casp3↑, cl‑PARP↑, PI3K/Akt↓, HK1↓, HK2↓, ROS↑, Apoptosis↑, eff↓, NADPH↓, PPP↓,
270- Api,    Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo via inactivation of Akt and activation of JNK
- in-vivo, AML, U937
Akt↓, JNK↑, Mcl-1↓, cl‑Bcl-2↓, Casp3↑, Casp7↑, Casp9↑, cl‑PARP↑, mTOR↓, GSK‐3β↓,
416- Api,    In Vitro and In Vivo Anti-tumoral Effects of the Flavonoid Apigenin in Malignant Mesothelioma
- vitro+vivo, MM, NA
Bax:Bcl2↑, P53↑, ROS↑, Casp9↑, Casp8↑, cl‑PARP1↑, p‑ERK⇅, p‑JNK↓, p‑p38↑, p‑Akt↓, cJun↓, NF-kB↓, EGFR↓, TumCCA↑,
2632- Api,    Apigenin inhibits migration and induces apoptosis of human endometrial carcinoma Ishikawa cells via PI3K-AKT-GSK-3β pathway and endoplasmic reticulum stress
- in-vitro, EC, NA
TumCP↓, TumCCA↑, Apoptosis↑, Bcl-2↓, BAX↑, Bak↑, Casp↑, ER Stress↑, Ca+2↑, ATF4↑, CHOP/DDIT3↑, ROS↑, MMP↓, TumCMig↓, TumCI↓, eff↑, P53↑, P21↑, Cyt‑c↑, Casp9↑, Casp3↑, Bcl-xL↓,
2634- Api,    Apigenin induces both intrinsic and extrinsic pathways of apoptosis in human colon carcinoma HCT-116 cells
- in-vitro, CRC, HCT116
TumCG↓, TumCCA↑, MMP↓, ROS↑, Ca+2↑, ER Stress↑, mtDam↑, CHOP/DDIT3↑, DR5↑, cl‑BID↑, BAX↑, Cyt‑c↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, Apoptosis↑,
2639- Api,    Plant flavone apigenin: An emerging anticancer agent
- Review, Var, NA
*antiOx↑, *Inflam↓, AntiCan↑, ChemoSen↑, BioEnh↑, chemoPv↑, IL6↓, STAT3↓, NF-kB↓, IL8↓, eff↝, Akt↓, PI3K↓, HER2/EBBR2↓, cycD1/CCND1↓, CycD3↓, p27/CDKN1B↑, FOXO3↑, STAT3↓, MMP2↓, MMP9↓, VEGF↓, Twist↓, MMP↓, ROS↑, NADPH↑, NRF2↓, SOD↓, COX2/PTGS2↓, p38↑, Telomerase↓, HDAC↓, HDAC1↓, HDAC3↓, Hif1a↓, angioG↓, uPA↓, Ca+2↑, Bax:Bcl2↑, Cyt‑c↑, Casp9↑, Casp12↑, Casp3↑, cl‑PARP↑, E-cadherin↑, β-catenin/ZEB1↓, cMyc↓, CDK4↓, CDK2↓, CDK6↓, IGF-1↓, CK2↓, CSCs↓, FAK↓, Gli↓, GLUT1↓,

Showing Research Papers: 1 to 50 of 515
Page 1 of 11 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 515

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,   NA⇅, 1,   NA?, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1,   antiOx↓, 2,   antiOx↑, 6,   antiOx⇅, 1,   ARE↓, 1,   Catalase↓, 14,   Catalase↑, 7,   Copper↑, 1,   Fenton↑, 2,   frataxin↑, 1,   GCLC↑, 1,   GCLM↓, 1,   GCLM↑, 1,   GPx↓, 5,   GPx↑, 3,   GPx4↓, 5,   GSH↓, 39,   GSH↑, 8,   GSH/GSSG↓, 4,   GSR↑, 3,   GSS↑, 1,   GSSG↓, 1,   GSSG↑, 1,   GSTs↓, 1,   GSTs↑, 3,   H2O2↓, 1,   H2O2↑, 7,   i-H2O2↑, 1,   HO-1↓, 7,   HO-1↑, 13,   HO-1↝, 1,   HO-2↓, 1,   Iron↑, 1,   Keap1↓, 1,   lipid-P↓, 8,   lipid-P↑, 13,   lipid-P↝, 1,   MDA↓, 5,   MDA↑, 5,   MPO↓, 1,   NADPH/NADP+↓, 1,   NOX4↑, 1,   NQO1↓, 1,   NQO1↑, 2,   Nrf1↑, 1,   NRF2↓, 17,   NRF2↑, 23,   p‑NRF2↓, 1,   p‑NRF2↑, 1,   Prx↓, 1,   Prx4↑, 1,   PrxII↓, 1,   ROS?, 4,   ROS↓, 24,   ROS↑, 261,   ROS⇅, 10,   ROS↝, 2,   ROS∅, 1,   i-ROS↓, 1,   i-ROS↑, 5,   mt-ROS↑, 7,   SAM-e↝, 1,   SOD?, 1,   SOD↓, 15,   SOD↑, 8,   SOD2↓, 3,   SOD2↑, 2,   TBARS↑, 2,   Thiols↓, 1,   Trx↓, 1,   Trx1↑, 1,   ox-Trx1↑, 1,   TrxR↓, 6,   TrxR1↓, 3,   xCT/SLC7A11↓, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 2,   FTL↑, 1,   IronCh↑, 3,   NCOA4↑, 1,   STEAP3↑, 1,   Tf↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 2,   BCR↓, 1,   CDC2↓, 8,   CDC25↓, 17,   CDC25↑, 1,   p‑CDC25↑, 1,   compI↓, 2,   compIII↓, 1,   compIV↓, 1,   compV↓, 1,   EGF↓, 4,   ETC↓, 1,   ETC↝, 1,   Insulin↓, 2,   MCU↓, 1,   MFN2↓, 1,   MFN2↑, 1,   mitResp↓, 2,   MKK7↓, 1,   mtDam↑, 32,   OCR↓, 3,   OXPHOS↓, 1,   mt-OXPHOS↓, 1,   PDH↓, 1,   PINK1↑, 2,   SDH↓, 2,   SIRT3↓, 2,   SIRT3↑, 3,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 6,   5LO↓, 2,   p‑ACC↑, 1,   ACLY↓, 2,   ACSL4↑, 1,   ACSL5↑, 2,   ALAT↓, 2,   ALAT↑, 1,   ALAT↝, 1,   ALDOA↓, 1,   AMP↑, 1,   AMPK↓, 1,   AMPK↑, 19,   AMPK↝, 1,   p‑AMPK↑, 1,   p‑AMT/GCST/T-protein↑, 1,   ATP↓, 14,   ATP↝, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   citrate↓, 1,   CPT1A↓, 1,   ECAR↝, 1,   ENO1↓, 2,   FASN↓, 2,   FASN↑, 2,   FBPase↑, 1,   glucoNG↑, 1,   GlucoseCon↓, 12,   Glycolysis↓, 21,   GSK‐3β↓, 10,   GSK‐3β↑, 6,   p‑GSK‐3β↓, 5,   p‑GSK‐3β↑, 1,   Histones↑, 1,   HK1↓, 1,   HK2↓, 10,   lactateProd↓, 9,   lactateProd↑, 1,   LDHA↓, 6,   LDL↓, 1,   NAD↝, 1,   NADPH↓, 2,   NADPH↑, 2,   O-Glc↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 6,   PFK↓, 1,   PFK1↓, 2,   PFK2?, 1,   PFK2↓, 2,   PFKP↓, 1,   PGK1↓, 1,   PKM2↓, 4,   PKM2∅, 1,   PLA2↓, 1,   polyA↓, 1,   PPP↓, 2,   Pyruv↓, 1,   p‑S6↓, 1,   SAT1↑, 1,   SIRT1↓, 5,   SIRT1↑, 2,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   TCA?, 1,   TCA↓, 2,   TCA↑, 1,   TS↓, 3,   Warburg↓, 3,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

14-3-3 proteins↓, 1,   AIF↑, 23,   APAF1↑, 19,   Apoptosis↓, 9,   Apoptosis↑, 287,   mt-Apoptosis↑, 4,   ASK1↑, 2,   BAD?, 1,   BAD↓, 4,   BAD↑, 21,   p‑BAD↓, 1,   Bak↓, 1,   Bak↑, 16,   BAX?, 1,   BAX↓, 2,   BAX↑, 233,   BAX⇅, 1,   BAX↝, 1,   Bax:Bcl2↓, 1,   Bax:Bcl2↑, 53,   Bcl-2↓, 230,   Bcl-2↑, 6,   Bcl-2↝, 1,   Bcl-2∅, 1,   cl‑Bcl-2↓, 1,   Bcl-xL↓, 55,   Bcl-xL↑, 2,   BID↓, 2,   BID↑, 17,   p‑BID↓, 1,   cl‑BID↑, 2,   BIM↑, 5,   BNIP3↑, 2,   BOK↑, 2,   Casp↑, 13,   Casp↝, 1,   Casp10↓, 1,   Casp10↑, 3,   Casp12?, 1,   Casp12↑, 10,   Casp12↝, 1,   cl‑Casp12↑, 1,   Casp2↑, 5,   Casp3↓, 6,   Casp3↑, 376,   cl‑Casp3↑, 65,   cl‑Casp3⇅, 1,   proCasp3↓, 2,   proCasp3↑, 4,   pro‑Casp3↑, 1,   CASP4↑, 2,   Casp6↑, 4,   Casp7↑, 41,   cl‑Casp7↑, 8,   Casp8↓, 2,   Casp8↑, 124,   Casp8∅, 2,   cl‑Casp8↑, 18,   proCasp8↓, 1,   proCasp8↑, 2,   pro‑Casp8↑, 1,   Casp9↓, 1,   Casp9↑, 441,   p‑Casp9↑, 2,   cl‑Casp9↑, 70,   proCasp9↓, 3,   proCasp9↑, 5,   pro‑Casp9↑, 1,   CellShr↑, 1,   cFLIP↓, 11,   Cyt‑c↓, 3,   Cyt‑c↑, 189,   Cyt‑c↝, 1,   Diablo↑, 10,   DR5↑, 37,   Endon↑, 1,   FADD↑, 14,   Fas↓, 2,   Fas↑, 31,   FasL↓, 1,   FasL↑, 22,   Ferroptosis↑, 5,   cl‑GSDME↑, 1,   HEY1↓, 1,   IAP1↓, 14,   IAP2/BIRC3↓, 4,   cl‑IAP2/BIRC3↑, 1,   ICD↑, 2,   iNOS↓, 16,   Mcl-1↓, 41,   Mcl-1↑, 1,   p‑Mcl-1↓, 1,   MDM2↓, 11,   MDM2↑, 2,   MLKL↑, 1,   p‑MLKL↓, 1,   MOMP↓, 1,   MOMP↑, 8,   NAIP↓, 2,   Necroptosis↑, 3,   necrosis↑, 2,   NOXA↑, 7,   p38↓, 6,   p38↑, 29,   p‑p38↓, 4,   p‑p38↑, 6,   PUMA↑, 6,   PUMA↝, 1,   Pyro↑, 1,   RIP3↑, 3,   p‑RIP3↑, 1,   survivin↓, 64,   survivin↝, 1,   TNFR 1↑, 2,   TRAIL↑, 9,   TRAILR↑, 2,   TumCD↓, 1,   TumCD↑, 22,   XIAP↓, 35,   XIAP↑, 1,   YAP/TEAD↓, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

ABL1↓, 1,   Akt?, 1,   Akt↓, 120,   Akt↑, 6,   p‑Akt↓, 45,   AKT1↓, 6,   Akt2↓, 2,   AMPKα↑, 1,   BRAF↝, 1,   CaMKII ↓, 2,   CK2↓, 4,   cMET↓, 3,   p‑cMET↑, 1,   CREB2↓, 1,   cSrc↓, 3,   EF-1α↓, 1,   EGFR↓, 31,   EGFR↑, 1,   p‑EGFR↓, 3,   ERK↓, 43,   ERK↑, 11,   p‑ERK↓, 17,   p‑ERK↑, 4,   p‑ERK⇅, 1,   e-ERK↑, 1,   FGFR1↓, 3,   FGFR2↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 13,   Hippo↑, 1,   HRAS↓, 2,   IGF-1R↓, 8,   IKKα↓, 5,   IKKα↑, 1,   p‑IKKα↓, 1,   IκB↑, 1,   p‑IκB↓, 2,   JAK↓, 3,   JAK1↓, 4,   JAK1↑, 1,   JAK2↓, 8,   p‑JAK2↓, 2,   JNK↓, 6,   JNK↑, 32,   p‑JNK↓, 5,   p‑JNK↑, 4,   cl‑JNK↑, 1,   LIMK1↓, 1,   MAP2K1/MEK1↓, 1,   MAPK↓, 33,   MAPK↑, 22,   MAPK↝, 2,   p‑MAPK↓, 1,   p‑MAPK↑, 1,   MEK↓, 6,   p‑MEK↓, 3,   p‑MEK↑, 1,   MKK4↓, 1,   mTOR↓, 56,   mTOR↑, 1,   mTOR↝, 2,   p‑mTOR↓, 16,   mTORC2↓, 3,   NRAS↓, 1,   p70S6↓, 2,   p70S6↑, 1,   P70S6K↓, 3,   p‑P70S6K↓, 2,   P90RSK↓, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 1,   PI3K↓, 87,   PI3K↑, 2,   p‑PI3K↓, 8,   PI3K/Akt↓, 6,   PI3K/Akt↝, 1,   PI3k/Akt/mTOR↝, 1,   PIAS-3↑, 1,   PIK3CA↓, 1,   PKA↓, 2,   PKCδ↓, 8,   p‑PKCδ↓, 1,   cl‑PKCδ↑, 1,   PTEN↓, 2,   PTEN↑, 31,   PTEN↝, 1,   Raf↓, 8,   c-Raf↓, 1,   RAS↓, 8,   RAS↑, 1,   RIP1↑, 1,   S6K↓, 1,   p‑S6K↓, 1,   SHP1↓, 1,   SHP1↑, 3,   Sp1/3/4↓, 5,   Src↓, 3,   STAT↓, 2,   STAT3↓, 53,   STAT3↑, 2,   p‑STAT3↓, 14,   p‑STAT3↑, 2,   STAT5↓, 2,   STAT6↓, 1,   TK1↓, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 2,   ATF4↑, 11,   ATF4↝, 1,   ATFs↑, 1,   ChrMod↝, 1,   cJun↓, 5,   cJun↑, 3,   p‑cJun↑, 2,   cMyc↓, 31,   cMyc↑, 1,   p‑cMyc↑, 1,   DNMT1↓, 7,   DNMT3A↓, 2,   DNMTs↓, 4,   EZH2↓, 2,   FOXM1↓, 1,   FOXO↑, 2,   FOXO1↑, 4,   FOXO3↓, 3,   FOXO3↑, 6,   FOXO4↑, 1,   GATA3↑, 1,   H3↑, 2,   ac‑H3↑, 1,   H4↑, 2,   ac‑H4↑, 1,   HATs↓, 6,   HATs↑, 1,   HDAC↓, 16,   HDAC1↓, 4,   HDAC10↑, 1,   HDAC2↓, 2,   HDAC3↓, 4,   HDAC8↓, 2,   HES1↓, 1,   HMTs↓, 1,   miR-106b↓, 1,   miR-133a-3p↑, 1,   miR-155↓, 3,   miR-17↓, 1,   miR-195↑, 1,   miR-21↓, 6,   miR-21↑, 1,   miR-221↓, 1,   miR-25-5p↓, 1,   miR-25-5p↑, 1,   miR-27a-3p↑, 1,   miR-339-5p↝, 1,   miR-34a↓, 1,   miR-34a↑, 2,   Myc↓, 5,   MYCN↓, 1,   n-MYC↓, 1,   OCT4↓, 8,   OCT4↑, 1,   other↓, 4,   other↑, 5,   other↝, 10,   PhotoS↑, 2,   SALL4↓, 1,   SETBP1↓, 1,   sonoS↑, 1,   SOX2↓, 6,   SOX4↓, 1,   SOX4↑, 2,   SUV39H↓, 2,   TCF-4↓, 2,   TET3↑, 1,   tumCV?, 1,   tumCV↓, 98,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 5,   cl‑ATF6↑, 1,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 30,   cl‑CHOP/DDIT3↑, 1,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 1,   eIF2α↑, 8,   p‑eIF2α↓, 1,   p‑eIF2α↑, 2,   ER Stress↓, 2,   ER Stress↑, 52,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 21,   GRP94↑, 4,   HSF1↓, 1,   HSP27↓, 7,   HSP27↝, 1,   HSP70/HSPA5↓, 4,   HSP70/HSPA5↑, 1,   HSP70/HSPA5↝, 1,   HSP72↓, 1,   HSP90↓, 10,   HSP90↑, 1,   HSPs↓, 1,   IRE1↑, 6,   PDI↑, 1,   PERK↑, 9,   p‑PERK↑, 1,   SERPINH1/HSP47↓, 1,   UPR↑, 7,   XBP-1↑, 3,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 9,   ATG5↝, 1,   ATG7↑, 2,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 21,   Beclin-1/ATG6↝, 1,   CTSB↓, 2,   CTSD↓, 2,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 4,   LC3A↑, 3,   LC3B↑, 2,   LC3B-II↑, 5,   LC3I↑, 1,   LC3II↓, 1,   LC3II↑, 7,   LC3s↑, 2,   MitoP↑, 2,   p62↓, 5,   p62↑, 3,   PARK2↑, 2,   SESN2↑, 1,   TumAuto↑, 41,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   ATM↑, 3,   p‑ATM↑, 2,   ATR↑, 1,   p‑BRCA1↑, 1,   DFF45↓, 2,   DFF45↑, 2,   DNA-PK↑, 2,   DNAdam↓, 2,   DNAdam↑, 83,   DNArepair↓, 2,   DNArepair↑, 1,   ERCC1↓, 1,   ERCC4/XPF↓, 1,   hTERT/TERT↓, 14,   Ku70/XRCC6↓, 1,   MGMT↓, 2,   p16↑, 3,   P53?, 1,   P53↓, 3,   P53↑, 119,   P53∅, 1,   p‑P53↓, 1,   p‑P53↑, 5,   p53 Wildtype↓, 1,   PARP↓, 4,   PARP↑, 41,   PARP↝, 1,   p‑PARP↑, 1,   cl‑PARP↓, 3,   cl‑PARP↑, 125,   PARP1↑, 2,   cl‑PARP1↑, 3,   PCNA↓, 27,   RAD51↓, 1,   SIRT6↑, 1,   Telomerase↓, 15,   TOP1↓, 2,   TOP2↓, 4,   TP53↑, 1,   UHRF1↓, 1,   γH2AX↑, 11,   γH2AX↝, 1,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 20,   CDK1↑, 4,   p‑CDK1↑, 1,   CDK2↓, 38,   CDK2↑, 4,   p‑CDK2↓, 1,   CDK4↓, 46,   CDK4↑, 3,   p‑CDK4↓, 1,   CDK6↓, 19,   CDK6↑, 2,   CDK8↓, 1,   CHK1↓, 2,   CHK1↑, 1,   p‑CHK1↑, 1,   Chk2↓, 2,   Chk2↑, 1,   ChrCon↑, 2,   Cyc↓, 2,   cycA1/CCNA1↓, 14,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 35,   CycB/CCNB1↑, 3,   cycD1/CCND1↓, 80,   cycD1/CCND1↑, 3,   p‑cycD1/CCND1↓, 1,   CycD3↓, 4,   cycE/CCNE↓, 25,   cycE/CCNE↑, 1,   cycE1↓, 1,   E2Fs↓, 3,   Ki-67↓, 15,   mitA↑, 2,   p19↑, 1,   P21?, 1,   P21↓, 4,   P21↑, 82,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 33,   pRB↑, 1,   p‑pRB↓, 2,   RB1↑, 1,   p‑RB1↓, 4,   Securin↓, 1,   TumCCA?, 1,   TumCCA↓, 10,   TumCCA↑, 199,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   ALDH↓, 3,   ALDH1A1↓, 2,   BMP7/OP1↓, 1,   BMPs↑, 1,   CD133↓, 7,   CD24↓, 2,   CD34↓, 1,   CEBPA↑, 1,   cFos↓, 5,   cMYB↓, 1,   CSCs↓, 26,   Diff↓, 1,   Diff↑, 3,   FGF↓, 4,   Gli↓, 1,   Gli1↓, 4,   HH↓, 3,   IGF-1↓, 8,   IGF-2↓, 1,   IGFBP3↑, 3,   JAG1↓, 1,   Jun↓, 1,   p‑Jun↑, 1,   Ki-67↓, 15,   Let-7↑, 3,   mTORC1↓, 5,   p‑mTORC1↓, 1,   Nanog↓, 6,   Nanog↑, 1,   Nestin↓, 3,   NICD↓, 1,   NOTCH↓, 11,   NOTCH1↓, 9,   NOTCH1↑, 1,   NOTCH3↓, 2,   OGFr↑, 2,   PTCH1↓, 1,   SCF↓, 1,   Shh↓, 5,   Smo↓, 3,   STAT1↓, 2,   TAZ↓, 1,   TumCG?, 2,   TumCG↓, 74,   TumCG↑, 3,   TumCP↓, 130,   TumCP↑, 3,   tyrosinase↓, 1,   URGCP/URG4↓, 1,   Wnt?, 1,   Wnt↓, 25,   Wnt/(β-catenin)↓, 6,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AntiAg?, 1,   AntiAg↓, 1,   AntiAg↑, 1,   AP-1↓, 11,   AP-1↑, 1,   BACH1↓, 1,   Ca+2↓, 6,   Ca+2↑, 45,   Ca+2↝, 6,   i-Ca+2↑, 4,   mt-Ca+2↑, 1,   CAFs/TAFs↓, 1,   Cal1↑, 2,   cal2↑, 5,   CCN2/CTGF↓, 1,   Cdc42↑, 1,   COL1↓, 2,   COL3A1↓, 1,   DLC1↑, 3,   E-cadherin↓, 7,   E-cadherin↑, 40,   EM↑, 1,   EMT↓, 51,   EMT↑, 2,   EMT↝, 1,   EpCAM↓, 1,   FAK↓, 16,   p‑FAK↓, 2,   Fibronectin↓, 1,   FOSB↑, 1,   GLI2↓, 1,   IQGAP3↓, 1,   ITGA5↓, 1,   ITGB1↓, 1,   ITGB3↓, 1,   ITGB4↓, 1,   KRAS↓, 1,   LAMs↓, 1,   LEF1↓, 1,   MALAT1↓, 1,   MMP1↓, 5,   MMP13↓, 3,   MMP2↓, 79,   MMP3↓, 5,   MMP7↓, 9,   MMP9↓, 92,   MMP9↑, 1,   MMPs↓, 27,   MUC4↓, 1,   N-cadherin↓, 29,   p‑p44↓, 1,   PAI-1/SERPINE1↑, 1,   PDGF↓, 4,   proline↓, 1,   Rac1↓, 1,   Rho↓, 2,   ROCK1↓, 2,   Slug?, 1,   Slug↓, 10,   Smad1↓, 1,   SMAD2↓, 1,   p‑SMAD2↓, 1,   SMAD3↓, 3,   SMAD3↑, 1,   p‑SMAD3↓, 1,   SMAD4↓, 1,   p‑SMAD4↓, 2,   Snail?, 1,   Snail↓, 26,   TET1↓, 1,   TET1↑, 3,   TGF-β↓, 16,   TGF-β↑, 3,   TIMP1↓, 3,   TIMP1↑, 9,   TIMP2↓, 3,   TIMP2↑, 12,   TIMP3↑, 1,   TSP-1↑, 3,   TumCA↓, 2,   TumCA↑, 1,   TumCI↓, 70,   TumCI↑, 1,   TumCMig↓, 56,   TumMeta↓, 47,   TumMeta↑, 3,   TumPF↓, 2,   Twist↓, 17,   uPA↓, 22,   uPAR↓, 1,   Vim↓, 31,   Zeb1↓, 11,   ZEB2↓, 3,   α-tubulin↓, 1,   α-tubulin↑, 1,   β-catenin/ZEB1↓, 34,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 72,   angioG↑, 1,   CD31/PECAM-1↓, 4,   Endoglin↑, 3,   HIF-1↓, 4,   Hif1a↓, 47,   Hif1a↑, 1,   NO↓, 3,   NO↑, 2,   VCAM-1↓, 3,   VEGF↓, 80,   VEGF↑, 1,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 15,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 4,   BBB∅, 2,   CLDN2↓, 1,   CLDN2↑, 1,   CX43/GJA1↓, 1,   EPR↑, 3,   GLUT1↓, 12,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↑, 1,   GLUT4↓, 1,   MMP?, 1,   MMP↓, 199,   MMP↑, 1,   MPT↑, 8,   NHE1↓, 1,   TRPM7↓, 1,   TRPV1↑, 1,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD4+↓, 1,   CD4+↑, 2,   CD44↓, 11,   CD8+↑, 1,   cDC2↓, 1,   p‑cDC2↑, 1,   COX1↓, 1,   COX2/PTGS2↓, 69,   CXCL1↓, 2,   CXCL12↓, 1,   CXCR2↓, 1,   CXCR4↓, 13,   CXCR4↑, 1,   DR4↑, 8,   DR4∅, 1,   FOXP3↓, 1,   FOXP3↑, 1,   HLA-I/II↑, 1,   HMGB1↓, 2,   ICAM-1↓, 4,   IFN-γ↓, 3,   IFN-γ↑, 2,   Igs↓, 1,   IL1↓, 4,   IL10↓, 3,   IL12↓, 2,   IL12↑, 1,   IL17↓, 1,   IL1β↓, 14,   IL2↓, 2,   IL2↑, 2,   IL4↓, 1,   IL6↓, 34,   IL8↓, 6,   Imm↑, 9,   Imm↝, 2,   Inflam↓, 29,   pol-M1↑, 1,   MCP1/CCL2↓, 4,   MCT1↓, 1,   NAF1↓, 1,   NF-kB↓, 119,   NF-kB↑, 3,   p‑NF-kB↓, 2,   p‑NF-kB↑, 2,   NK cell↑, 3,   p50↓, 1,   p65↓, 6,   PD-1↓, 1,   PD-L1↓, 3,   PGE2↓, 18,   PSA↓, 7,   RAGE↓, 2,   SOCS-3↓, 1,   T-Cell↑, 2,   T-Cell↝, 1,   Th1 response↑, 2,   Th17↑, 1,   TLR4↓, 2,   TNF-α↓, 30,   TNF-α↑, 5,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,   TRADD↑, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GGT/CD224↑, 1,   IM↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   AR↓, 11,   ER-α36↓, 1,   PPARα↓, 1,   cl‑PPARα↓, 1,   PPARγ↓, 2,   PPARγ↑, 3,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 1,   AKR1B10↓, 1,   BioAv↓, 30,   BioAv↑, 35,   BioAv↝, 5,   BioEnh↑, 4,   ChemoSen?, 2,   ChemoSen↓, 3,   ChemoSen↑, 109,   ChemoSen↝, 1,   CompStab↑, 3,   CompStab↝, 2,   CYP1A1↓, 2,   CYP1A1↑, 1,   CYP1B1↑, 1,   CYP3A4↓, 2,   DDS↑, 1,   Dose?, 5,   Dose↓, 4,   Dose↑, 9,   Dose⇅, 1,   Dose↝, 42,   Dose∅, 7,   eff↓, 76,   eff↑, 68,   eff↝, 8,   GSTA1↓, 1,   GSTA1↑, 1,   Half-Life↓, 3,   Half-Life↑, 1,   Half-Life↝, 10,   MDR1↓, 4,   MRP1/ABCC1↓, 2,   MRP1/ABCC1↝, 1,   P-gp/ABCB1↓, 12,   P450↓, 4,   RadioS↑, 36,   selectivity?, 1,   selectivity↓, 2,   selectivity↑, 90,   Synergy?, 1,   Synergy↑, 75,   TET2↓, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 2,   ALAT↑, 1,   ALAT↝, 1,   ALP↝, 1,   AR↓, 11,   AST↓, 2,   AST↑, 1,   AST↝, 1,   BRAF↝, 1,   p‑BRCA1↑, 1,   CEA↓, 1,   CRP↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 31,   EGFR↑, 1,   p‑EGFR↓, 3,   EZH2↓, 2,   FOXM1↓, 1,   HER2/EBBR2↓, 13,   hTERT/TERT↓, 14,   IL6↓, 34,   KRAS↓, 1,   LDH↓, 5,   LDH↑, 5,   LDH↝, 2,   Myc↓, 5,   PD-L1↓, 3,   PSA↓, 7,   RAGE↓, 2,   TP53↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 42,   antiD↑, 1,   antiNeop↑, 1,   AntiTum↑, 22,   cachexia↓, 2,   cardioP↑, 4,   CardioT↑, 1,   chemoP↑, 20,   chemoPv↑, 18,   chemoPv⇅, 1,   ChemoSideEff↓, 4,   hepatoP↓, 1,   hepatoP↑, 7,   neuroP↑, 1,   NP/CIPN↓, 1,   OS↑, 7,   Pain↓, 2,   PFS↓, 1,   Pin1↓, 2,   QoL↑, 3,   QoL∅, 1,   radioP↑, 4,   RenoP↑, 7,   Risk↓, 10,   Strength↑, 1,   toxicity↓, 12,   toxicity↑, 4,   toxicity↝, 4,   toxicity∅, 1,   TumNum↓, 2,   TumVol↓, 23,   TumVol↑, 1,   TumW↓, 14,   Weight↑, 1,   Weight∅, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↑, 1,   Bacteria↓, 2,   GutMicro↑, 2,   GutMicro↝, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 7,  
Total Targets: 1010

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 5,   antiOx↑, 60,   Catalase↑, 30,   GPx↑, 20,   GSH↑, 25,   GSR↑, 2,   GSTs↑, 10,   H2O2↓, 1,   HDL↑, 1,   HO-1↓, 1,   HO-1↑, 8,   Keap1↓, 1,   Keap1↑, 1,   Keap1↝, 1,   lipid-P↓, 18,   MDA↓, 17,   MPO↓, 2,   NADH↓, 1,   NQO1↑, 2,   NRF2↑, 21,   Prx↑, 1,   RNS↓, 2,   ROS↓, 67,   ROS↑, 1,   ROS⇅, 1,   ROS∅, 1,   mt-ROS?, 1,   SOD↓, 1,   SOD↑, 27,   SOD2↑, 1,   TAC↑, 3,   TBARS↓, 2,   Trx↑, 1,   uricA↓, 1,   VitC↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 2,   IronCh↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↑, 1,   PGC-1α↑, 2,   PGC-1α↝, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   5LO↓, 1,   ALAT↓, 8,   AMPK↑, 2,   ATP↑, 3,   DGAT1↓, 1,   FASN↓, 1,   glucose↓, 3,   GlucoseCon↑, 1,   GSK‐3β↓, 1,   H2S↑, 2,   LDHA↑, 1,   LDL↓, 3,   lipidLev↓, 2,   NAD↑, 1,   NADPH↓, 1,   NADPH↑, 2,   PLA2↓, 1,   SIRT1↑, 4,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   Apoptosis↓, 2,   Apoptosis∅, 1,   BAX↓, 4,   Bcl-2↑, 1,   Casp↓, 1,   Casp3?, 1,   Casp3↓, 7,   Casp9↓, 1,   Cyt‑c↓, 2,   Fas↓, 1,   FasL↓, 1,   iNOS↓, 8,   necrosis↓, 1,   p38↓, 1,   Pyro↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   Akt↑, 4,   p‑Akt↓, 1,   p‑Akt↑, 1,   Akt2↓, 1,   CREB↑, 1,   ERK↓, 3,   ERK↑, 1,   IKKα↓, 1,   IKKα↑, 1,   IκB?, 1,   JAK↓, 1,   JNK↓, 2,   MAPK↓, 4,   mTOR↓, 1,   mTOR↑, 3,   PDGFR-BB↓, 1,   PDGFRB↓, 1,   PI3K↓, 4,   PI3K↑, 4,   PKCδ↓, 1,   PKCδ↑, 1,   STAT3↓, 2,   STAT3↑, 1,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 2,   cJun↓, 1,   p‑cMyc↑, 1,   HDAC↓, 2,   HDAC3↓, 1,   HOTAIR↑, 1,   other↓, 2,   other↑, 3,   other↝, 1,   RUNX2↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

HSP27↑, 1,   HSPs↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 3,   Beclin-1/ATG6↑, 1,   LC3II↑, 1,   p62↑, 2,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 3,   p16↓, 1,   P53↓, 2,   PARP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

Ki-67↓, 1,   P21↓, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMP2↑, 1,   Diff↝, 1,   Ki-67↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AP-1↓, 1,   Ca+2↓, 1,   COL1↑, 1,   MLC2/MYL9↝, 1,   MMP13↓, 2,   p‑Rac1↓, 1,   TregCell↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   Hif1a↓, 3,   Hif1a↑, 1,   NO↓, 6,   VCAM-1↓, 2,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 7,   GastroP↑, 3,   GLUT4↑, 1,   IBI↑, 1,   MMP↑, 5,   OCLN↝, 1,   TJ↑, 1,   TRPA1↑, 1,   TRPC1↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD19↑, 1,   CD4+↑, 2,   CD40↓, 1,   CD8+↑, 1,   COX1↓, 2,   COX2/PTGS2↓, 15,   COX2/PTGS2↑, 1,   IFN-γ↓, 1,   IL1↓, 1,   IL10↓, 5,   IL10↑, 2,   IL18↓, 1,   IL1β↓, 8,   IL2↓, 1,   IL4↓, 1,   IL5↓, 1,   IL6↓, 17,   IL6↑, 1,   IL8↓, 3,   Imm↑, 5,   Inflam↓, 70,   Inflam↑, 1,   IP-10/CXCL-10↓, 1,   pol-M2 MC↑, 1,   NeuroI↓, 1,   NF-kB↓, 19,   NK cell↑, 1,   NLRP3↓, 2,   PGE2↓, 7,   TLR4↓, 1,   TNF-α↓, 23,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 1,   AChE↓, 9,   BChE↓, 3,   BDNF↑, 5,   MAOA↓, 1,   NGF↑, 2,   TPH1↓, 1,   TrkB↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 6,   BACE/β-secretase↓, 2,   tau↓, 2,   p‑tau↓, 2,   XO↝, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

PPARα↑, 1,   PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 23,   BioAv↑, 22,   BioAv⇅, 1,   BioAv↝, 10,   CYP2D6↓, 1,   CYP2E1↓, 1,   Dose↝, 3,   eff↓, 1,   eff↑, 6,   GSTA1↑, 1,   Half-Life↓, 2,   Half-Life↑, 2,   Half-Life↝, 8,   P-gp/ABCB1↓, 1,   P450↓, 1,   selectivity↑, 1,   Synergy↑, 5,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 8,   ALP↓, 4,   AST↓, 7,   BG↓, 1,   BP↓, 4,   creat↓, 5,   CRP↓, 2,   hs-CRP↓, 1,   IL6↓, 17,   IL6↑, 1,   LDH↓, 4,   NOS2↓, 1,   Urea↓, 2,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 1,   antiAll↑, 10,   AntiArt↑, 4,   AntiCan↑, 14,   antiCG↑, 1,   AntiDiabetic↑, 19,   antiNeop↑, 1,   antiPs↑, 3,   AntiTum↓, 2,   AntiTum↑, 5,   cardioP↑, 26,   chemoP↑, 4,   chemoPv↑, 1,   cognitive↑, 6,   diuretic↑, 2,   hepatoP↑, 23,   memory↑, 4,   motorD↑, 1,   Mucositis↓, 2,   neuroP↓, 1,   neuroP↑, 36,   Obesity↓, 4,   Pain↓, 2,   radioP↑, 2,   RenoP↑, 5,   Stroke↓, 4,   toxicity?, 1,   toxicity↓, 34,   toxicity↑, 3,   toxicity↝, 6,   toxicity∅, 6,   Wound Healing↑, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 13,   AntiFungal↓, 1,   AntiFungal↑, 3,   AntiP↑, 2,   AntiViral↑, 7,   Bacteria↓, 14,   Diar↓, 2,   GutMicro↑, 8,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 4,  
Total Targets: 274

Scientific Paper Hit Count for: Casp9, Caspase-9
21 Quercetin
18 Silver-NanoParticles
15 Baicalein
15 Curcumin
14 Thymoquinone
13 Fisetin
12 Kaempferol
12 Luteolin
12 Sulforaphane (mainly Broccoli)
11 Emodin
10 Apigenin (mainly Parsley)
10 Magnolol
9 Allicin (mainly Garlic)
9 Berberine
9 Betulinic acid
8 Chrysin
8 Morin
7 EGCG (Epigallocatechin Gallate)
7 Gambogic Acid
7 Honokiol
7 Silymarin (Milk Thistle) silibinin
6 Cisplatin
6 Artemisinin
6 Allyl isothiocyanate
6 Phenethyl isothiocyanate
6 Citric Acid
6 Eugenol
6 Garcinol
6 Graviola
5 Benzyl isothiocyanate
5 D-limonene
5 Ginkgetin
5 Ivermectin
5 Shikonin
4 Cynara scolymus/Globe Artichoke/Artichoke Extract
4 Alpha-Lipoic-Acid
4 Ashwagandha(Withaferin A)
4 Bromelain
4 Capsaicin
4 Carvacrol
4 chaetocin
4 Photodynamic Therapy
4 Radiotherapy/Radiation
4 Formononetin
4 Fucoidan
4 Juglone
4 Licochalcone A
4 Matrine
4 Magnetic Fields
4 Plumbagin
4 Resveratrol
3 5-fluorouracil
3 Berbamine
3 Boron
3 Boswellia (frankincense)
3 Carnosic acid
3 Evodiamine
3 Ferulic acid
3 Gallic acid
3 Geraniol
3 Gossypol/AT-101
3 HydroxyTyrosol
3 Hyperoside
3 Isoliquiritigenin
3 Vitexin
3 Licorice
3 Mushroom Lion’s Mane, Hericium erinaceus
3 Propolis -bee glue
3 Piperlongumine
3 Selenium NanoParticles
3 Aflavin-3,3′-digallate
2 Astragalus
2 Andrographis
2 Anethole/trans-Anethole
2 Aloe anthraquinones
2 Beta-Caryophyllene
2 Brucea javanica
2 α-Bisabolol / Chamomile oil
2 Thymol-Thymus vulgaris
2 Centella asiatica / Gotu kola → asiaticoside
2 Chlorogenic acid
2 Cichoric acid / Chicoric acid
2 Carvone
2 Polyphenols
2 Deguelin
2 Docetaxel
2 Dandelion Root
2 Echinacea
2 Electrical Pulses
2 Paclitaxel/Taxol
2 Hibiscus sabdariffa
2 Rutin
2 Isobavachalcone
2 phytic acid, Inositol hexakisphosphate
2 Isorhamnetin
2 isoorientin
2 lambertianic acid
2 low dose naltrexone
2 Lycopene
2 methylseleninic acid
2 Mangiferin
2 doxorubicin
2 Mistletoe/Viscum album Extracts
2 Nimbolide
2 Oleuropein
2 Phycocyanin
2 salinomycin
2 Selenium
2 chitosan
2 Selenite (Sodium)
2 Ursolic acid
1 1,8-Cineole
1 entinostat
1 Camptothecin
1 Resiquimod
1 Gemcitabine (Gemzar)
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Fennel Oil/Foeniculum vulgare
1 Metformin
1 2-DeoxyGlucose
1 almonertinib
1 epirubicin
1 Biochanin A
1 Bufalin/Huachansu
1 brusatol
1 borneol
1 Bullatacin
1 Caffeic acid
1 Sorafenib (brand name Nexavar)
1 Celecoxib
1 Celastrol
1 Chlorophyllin
1 Cinnamon
1 immunotherapy
1 Crocetin
1 Cucurbitacin
1 Cynaropicrin
1 Diclofenac
1 diet Methionine-Restricted Diet
1 Ellagic acid
1 Geldanamycin
1 Radicicol/monorden
1 Flaxseed/Linseed
1 olaparib/LYNPARZA
1 Ginkgolic acids
1 Ginger/6-Shogaol/Gingerol
1 Ginseng
1 Hydroxycinnamic-acid
1 Helleborus niger extracts – Christmas Rose
1 Baicalin
1 Indole-3-carbinol
1 carboplatin
1 isoquercitrin
1 Isovitexin
1 Lactobacillus
1 tumor necrosis factor-related apoptosis-inducing ligand
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 Linalool
1 Chemotherapy
1 Magnetic Field Rotating
1 Moringin
1 Melatonin
1 Moringa oleifera
1 Methylsulfonylmethane
1 Marjoram (Origanum majorana)
1 Patchouli Oil (Pogostemon cablin)
1 sericin
1 Propyl gallate
1 topotecan
1 Rauwolfia serpentina/Indian Snakeroot
1 buckwheat sprouts
1 Sanguinarine
1 polyethylene glycol
1 Auranofin
1 Spirulina(Arthrospira/Limnospira)
1 Terpinen-4-ol / Tea Tree Oil
1 Urolithin
1 Vitamin C (Ascorbic Acid)
1 Vitamin D3
1 Vitamin K2
1 VitK3,menadione
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:45  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page